Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management

The Journal of Pediatrics
Elpis MantadakisGeorge R Buchanan

Abstract

To determine the incidence of immune thrombocytopenic purpura (ITP) after measles-mumps-rubella (MMR) immunization compared with natural measles and rubella, its clinical course and outcome, and the risk of recurrence after repeat MMR vaccination. We performed a systematic review of the Ovid MEDLINE (1950 to present) bibliographic database. We selected studies that reported cases of thrombocytopenia in a known number of children who were immunized with MMR vaccine before development of ITP. We also extracted data from the same and other studies regarding bleeding manifestations and the resolution of MMR-associated thrombocytopenia or thrombocytopenic purpura within 6 months. Finally, we studied the risk of ITP recurrence after MMR immunization or reimmunization. On the basis of 12 studies, the incidence of MMR-associated ITP ranged from 0.087 to 4 (median 2.6) cases per 100,000 vaccine doses. Severe bleeding manifestations were rare, and MMR-associated thrombocytopenia resolved within 6 months from diagnosis in 93% of the children. MMR vaccination of unimmunized patients with ITP and revaccination of patients with prior ITP did not lead to recurrence of thrombocytopenia. MMR-associated ITP is rare, self-limited, and non-life th...Continue Reading

References

Jan 1, 1968·American Journal of Diseases of Children·H J AlterG P Schechter
Dec 16, 1965·The New England Journal of Medicine·W L BayerJ H Lewis
Apr 1, 1966·Archives of Internal Medicine·E E MorseD P Jackson
Feb 1, 1967·American Journal of Diseases of Children·A J BachandA N Morrison
May 1, 1967·American Journal of Diseases of Children·D J Wilhelm, R D Paegle
Jun 1, 1996·Journal of Internal Medicine·U Pedersen-BjergaardP B Hansen
Nov 11, 1999·British Journal of Haematology·J S Lilleyman
Oct 18, 2000·Pediatric Hematology and Oncology·B ZellerF Wesenberg
Feb 24, 2001·Archives of Disease in Childhood·E MillerB Taylor
Jan 22, 2003·British Journal of Clinical Pharmacology·Corri BlackHershel Jick
Aug 19, 2003·Vaccine·Tom JeffersonUNKNOWN European Research Program for Improved Vaccine Safety Surveillance (EUSAFEVAC) Project
Dec 21, 1963·British Medical Journal·R A SLADDEN
Nov 28, 2006·Vaccine·J RajantieUNKNOWN NOPHO ITP working group and five national study groups
May 12, 2007·Vaccine·Robert P WiseUNKNOWN Brighton Collaboration Thrombocytopenia Working Group
Oct 27, 2007·Archives of Disease in Childhood·Julia StoweElizabeth Miller
Mar 4, 2008·Pediatrics·Eric K FranceUNKNOWN Vaccine Safety Datalink Team
Mar 4, 2008·Pediatrics·M Miles Braun
Aug 22, 2008·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)

❮ Previous
Next ❯

Citations

Dec 14, 2011·Journal of Veterinary Internal Medicine·A A HuangJ C Scott-Moncrieff
Aug 31, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·D MentzerB Keller-Stanislawski
Mar 19, 2014·La Presse médicale·Douglas B CinesJohn W Semple
Jan 7, 2014·European Journal of Pediatrics·Veerle Labarque, Chris Van Geet
Nov 13, 2012·The Journal of Emergency Medicine·Mustafa SerinkenOzgur Karcioglu
Jul 17, 2012·The Journal of Emergency Medicine·Gil Z Shlamovitz, Sandeep Johar
Apr 17, 2012·Human Immunology·Gregory A Poland, Robert M Jacobson
Nov 29, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Carlo PerriconeYehuda Shoenfeld
Jun 1, 2012·Pediatrics International : Official Journal of the Japan Pediatric Society·Eftichia StiakakiMaria Kalmanti
Sep 17, 2013·Pediatric Blood & Cancer·Jessica A ReeseJames N George
Mar 18, 2016·Expert Opinion on Drug Safety·Nicola Principi, Susanna Esposito
Aug 23, 2011·Lancet·William J Moss, Diane E Griffin
May 17, 2013·Seminars in Hematology·Dana YehudaiZahava Vadasz
Jan 18, 2013·Human Vaccines & Immunotherapeutics·Valerio CecinatiSusanna Esposito
Oct 27, 2012·Blood·Lamiae Grimaldi-BensoudaUNKNOWN PGRx Immune Thrombocytopenia Study Group
Feb 18, 2011·Blood·Cindy NeunertUNKNOWN American Society of Hematology
Dec 27, 2017·International Journal of Environmental Research and Public Health·Yong LiLianwen Wang
Aug 24, 2012·Pharmacoepidemiology and Drug Safety·Kumanan Wilson, Steven Hawken
Jun 12, 2010·Journal of Pediatric Hematology/oncology·Elpis MantadakisAthanassios Chatzimichael
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Vittorio DemicheliCarlo Di Pietrantonj
Sep 22, 2019·BMJ Case Reports·Estelle Morin, Manish Sadarangani
Apr 21, 2020·The Cochrane Database of Systematic Reviews·Carlo Di PietrantonjVittorio Demicheli
Aug 22, 2020·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Sylvie EscolanoPascale Tubert-Bitter
Apr 8, 2019·Paediatrics & Child Health·Chi Yon SeoShelley L Deeks
Jul 25, 2019·Nature·Saad B OmerJulie Leask
Nov 22, 2011·Platelets·Guillaume MoulisUNKNOWN French Association Of Regional Pharmacovigilance Centers
May 16, 2018·Frontiers in Immunology·Maurice SwinkelsA J Gerard Jansen
Feb 23, 2020·Public Health Ethics·Alberto Giubilini, Julian Savulescu
Dec 31, 2020·International Medical Case Reports Journal·Majd AkbikAzzam Ashour
Jun 11, 2021·Nature Medicine·Allyson M PishkoDouglas B Cines
Jul 2, 2021·Journal of Global Infectious Diseases·Sachin BansalPrabhat Agrawal
Aug 29, 2021·Vaccines·Marek PetrášAlexander M Čelko
Oct 10, 2021·International Journal of Hematology·Junichi KitazawaUNKNOWN Platelet Committee of the Japanese Society of Pediatric Hematology/Oncology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Vaccine
J RajantieNOPHO ITP working group and five national study groups
Archives of Disease in Childhood
E MillerB Taylor
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
Luc J M MortelmansJutten Y C Guido
© 2021 Meta ULC. All rights reserved